Shoulder Innovations (NYSE:SI) COO Matthew Fraser Ahearn Sells 15,856 Shares

by · The Markets Daily

Shoulder Innovations, Inc. (NYSE:SI – Get Free Report) COO Matthew Fraser Ahearn sold 15,856 shares of the firm’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $18.68, for a total value of $296,190.08. Following the completion of the sale, the chief operating officer owned 273,320 shares of the company’s stock, valued at approximately $5,105,617.60. This represents a 5.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

  • On Monday, June 15th, Matthew Fraser Ahearn sold 4,144 shares of Shoulder Innovations stock. The shares were sold at an average price of $18.84, for a total value of $78,072.96.

Shoulder Innovations Stock Up 3.6%

NYSE SI traded up $0.66 during trading hours on Tuesday, hitting $18.78. The company’s stock had a trading volume of 165,354 shares, compared to its average volume of 81,765. Shoulder Innovations, Inc. has a 52 week low of $10.92 and a 52 week high of $19.79. The company has a market capitalization of $389.43 million and a PE ratio of -0.11. The company has a current ratio of 11.81, a quick ratio of 10.04 and a debt-to-equity ratio of 0.11. The company’s 50-day simple moving average is $14.56 and its two-hundred day simple moving average is $14.38.

Shoulder Innovations (NYSE:SI – Get Free Report) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.03. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. The business had revenue of $16.71 million for the quarter. Research analysts anticipate that Shoulder Innovations, Inc. will post -1.67 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Deerfield Management Company L.P. bought a new position in Shoulder Innovations in the third quarter worth approximately $6,056,000. Alyeska Investment Group L.P. bought a new position in Shoulder Innovations in the third quarter worth approximately $5,667,000. TimesSquare Capital Management LLC bought a new position in Shoulder Innovations in the third quarter worth approximately $4,799,000. Vanguard Group Inc. bought a new position in Shoulder Innovations in the third quarter worth approximately $1,836,000. Finally, Roubaix Capital LLC raised its position in Shoulder Innovations by 61.9% in the first quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after acquiring an additional 98,305 shares during the period.

Analysts Set New Price Targets

A number of research firms have recently issued reports on SI. BTIG Research lifted their price objective on shares of Shoulder Innovations from $23.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, March 11th. Piper Sandler reaffirmed an “overweight” rating and set a $19.00 price objective (up from $18.00) on shares of Shoulder Innovations in a report on Friday, May 8th. Five analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $21.00.

Get Our Latest Research Report on Shoulder Innovations

Shoulder Innovations Company Profile

(Get Free Report)

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.

Read More